Avoidance of bioflavonoid supplements during pregnancy [12]

Lancet

Volumn 361, Issue 9353, 2003, Pages 261-262

  Clementi, Maurizio ^a   Giavini, Erminio ^b   Mantovani, Alberto ^c  

^a Clinical Genetics Service   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Department of Environment and Health Section of Water and Health   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFLAVONOID; FLAVONOID;

ANTIOXIDANT ACTIVITY; CANCER PREVENTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; LETTER; LEUKEMIA; MEDICAL LITERATURE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

EID: 0037452136     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12297-0     Document Type: Letter

References (5)

1. Ross J.A. Dietary flavonoids and the MLL gene: a pathway to infant leukemia? Proc Natl Acad Sci USA. 97:2000;4411-4413.
2. Strick R., Strissel P.L., Borgers S., Smith S.L., Rowley J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukaemia. Proc Natl Acad Sci USA. 97:2000;4790-4795.
3. Barnes S. Phytoestrogen and breast cancer. Baillieres Clin Endocr Metab. 12:1998;559-579.
4. Nagata C., Takatsuka N., Shimizu H., Hayashi H., Akamatsu T., Murase K. Effect of soymilk consumption on serum estrogen and androgen in Japanese men. Cancer Epidemiol Biomarker Prev. 10:2001;179-184.
5. Pillow P.C., Duphorne C.M., Chang S., et al. Development of a data base for assessing dietary phytoestrogen intake. Nutr Cancer. 33:1999;3-19.